28 May 2013 – Parsortix Manufacturer appointed
The group has appointed a manufacturer for its Parsortix cancer diagnostic product with Cogent Technology Limited being chosen after a thorough selection process. The group continues to look to outsource its manufacturing as this is more cost-effective – this is another positive step for the group and the shares remain a BUY .